Trans health expert on navigating the use of treatments like puberty blockers for minors in the U.S.

The UK has limited the use of puberty-blocking hormones in minors, citing a lack of strong evidence on the drugs' long-term impacts on children and adolescents. The move has been criticized by some health care practitioners, patients and advocates.

How is the decision to pull back on these medicines in young people affecting gender-affirming care in the United States? Here & Now's Scott Tong speaks with Erica Anderson, who is a clinical psychologist, transgender health expert and trans woman.